<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Icosabutate, a Novel Structurally Engineered Fatty-Acid, Exhibits Potent Anti-Inflammatory and Anti-Fibrotic Effects in a Dietary Mouse Model Resembling Progressive Human Non-Alcoholic Steatohepatitis

Simple item page
dc.contributor.authorFraser, David
dc.contributor.authorWang, Xiaoyu
dc.contributor.authorSkjaeret, Tore
dc.contributor.authorSchuppan, Detlef
dc.date.accessioned2026-11-05T11:01:59Z
dc.date.issued2018
dc.description.pages749A-750A
dc.description.volume68
dc.identifier.issn0270-9139
dc.identifier.issn1527-3350
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/10837
dc.identifier.wosWOS:000446020502093
dc.language.isoen
dc.publisherWILEY
dc.relation.conferenceAnnual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting
dc.relation.ispartofHEPATOLOGY
dc.subjectGastroenterology & Hepatology
dc.titleIcosabutate, a Novel Structurally Engineered Fatty-Acid, Exhibits Potent Anti-Inflammatory and Anti-Fibrotic Effects in a Dietary Mouse Model Resembling Progressive Human Non-Alcoholic Steatohepatitis
dc.typeMeeting Abstract
oaire.citation.editionScience Citation Index Expanded (SCI-EXPANDED)
oaire.citation.editionConference Proceedings Citation Index - Science (CPCI-S)
oaire.citation.endPage750A
oaire.citation.startPage749A
oaire.citation.volume68
person.identifier.ridAER-9743-2022

Files

Collections

WOS